Literature DB >> 23187726

Personality trait predictors of placebo analgesia and neurobiological correlates.

Marta Peciña1, Hamdan Azhar, Tiffany M Love, Tingting Lu, Barbara L Fredrickson, Christian S Stohler, Jon-Kar Zubieta.   

Abstract

Personality traits have been shown to interact with environmental cues to modulate biological responses including treatment responses, and potentially having a role in the formation of placebo effects. Here, we assessed psychological traits in 50 healthy controls as to their capacity to predict placebo analgesic effects, placebo-induced activation of μ-opioid neurotransmission and changes in cortisol plasma levels during a sustained experimental pain challenge (hypertonic saline infused in the masseter muscle) with and without placebo administration. Statistical analyses showed that an aggregate of scores from Ego-Resiliency, NEO Altruism, NEO Straightforwardness (positive predictors) and NEO Angry Hostility (negative predictor) scales accounted for 25% of the variance in placebo analgesic responses. Molecular imaging showed that subjects scoring above the median in a composite of those trait measures also presented greater placebo-induced activation of μ-opioid neurotransmission in the subgenual and dorsal anterior cingulate cortex (ACC), orbitofrontal cortex, insula, nucleus accumbens, amygdala and periaqueductal gray (PAG). Endogenous opioid release in the dorsal ACC and PAG was positively correlated with placebo-induced reductions in pain ratings. Significant reductions in cortisol levels were observed during placebo administration and were positively correlated with decreases in pain ratings, μ-opioid system activation in the dorsal ACC and PAG, and as a trend, negatively with NEO Angry Hostility scores. Our results show that personality traits explain a substantial proportion of the variance in placebo analgesic responses and are further associated with activations in endogenous opioid neurotransmission, and as a trend cortisol plasma levels. This initial data, if replicated in larger sample, suggest that simple trait measures easily deployable in the field could be utilized to reduce variability in clinical trials, but may also point to measures of individual resiliency in the face of aversive stimuli such as persistent pain and potentially other stressors.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23187726      PMCID: PMC3572460          DOI: 10.1038/npp.2012.227

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  45 in total

Review 1.  Psychobiological mechanisms of resilience and vulnerability: implications for successful adaptation to extreme stress.

Authors:  Dennis S Charney
Journal:  Am J Psychiatry       Date:  2004-02       Impact factor: 18.112

2.  An analysis of the placebo phenomenon.

Authors:  R LIBERMAN
Journal:  J Chronic Dis       Date:  1962-08

3.  Mechanisms of placebo analgesia: rACC recruitment of a subcortical antinociceptive network.

Authors:  U Bingel; J Lorenz; E Schoell; C Weiller; C Büchel
Journal:  Pain       Date:  2005-12-20       Impact factor: 6.961

4.  Placebo effects on human mu-opioid activity during pain.

Authors:  Tor D Wager; David J Scott; Jon-Kar Zubieta
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-19       Impact factor: 11.205

5.  Dispositional optimism predicts placebo analgesia.

Authors:  Andrew L Geers; Justin A Wellman; Stephanie L Fowler; Suzanne G Helfer; Christopher R France
Journal:  J Pain       Date:  2010-06-02       Impact factor: 5.820

6.  Arcuate nucleus projections to brainstem regions which modulate nociception.

Authors:  L J Sim; S A Joseph
Journal:  J Chem Neuroanat       Date:  1991 Mar-Apr       Impact factor: 3.052

7.  COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor.

Authors:  Jon-Kar Zubieta; Mary M Heitzeg; Yolanda R Smith; Joshua A Bueller; Ke Xu; Yanjun Xu; Robert A Koeppe; Christian S Stohler; David Goldman
Journal:  Science       Date:  2003-02-21       Impact factor: 47.728

Review 8.  Pain-related effects of trait anger expression: neural substrates and the role of endogenous opioid mechanisms.

Authors:  Stephen Bruehl; John W Burns; Ok Y Chung; Melissa Chont
Journal:  Neurosci Biobehav Rev       Date:  2008-12-25       Impact factor: 8.989

9.  Personality trait predictors of bipolar disorder symptoms.

Authors:  Lena Catherine Quilty; Martin Sellbom; Jennifer Lee Tackett; Robert Michael Bagby
Journal:  Psychiatry Res       Date:  2009-08-21       Impact factor: 3.222

10.  Endogenous opioids may buffer effects of anger arousal on sensitivity to subsequent pain.

Authors:  John W Burns; Stephen Bruehl; Ok Y Chung; Edward Magid; Melissa Chont; James K Goodlad; Wesley Gilliam; Justin Matsuura; Kristin Somar
Journal:  Pain       Date:  2009-08-13       Impact factor: 6.961

View more
  52 in total

1.  Placebo improves pleasure and pain through opposite modulation of sensory processing.

Authors:  Dan-Mikael Ellingsen; Johan Wessberg; Marie Eikemo; Jaquette Liljencrantz; Tor Endestad; Håkan Olausson; Siri Leknes
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-14       Impact factor: 11.205

2.  Effects of the Mu opioid receptor polymorphism (OPRM1 A118G) on pain regulation, placebo effects and associated personality trait measures.

Authors:  Marta Peciña; Tiffany Love; Christian S Stohler; David Goldman; Jon-Kar Zubieta
Journal:  Neuropsychopharmacology       Date:  2014-10-13       Impact factor: 7.853

3.  Between placebo and nocebo: Response to control treatment is mediated by amygdala activity and connectivity.

Authors:  Natalia Egorova; Fabrizio Benedetti; Randy L Gollub; Jian Kong
Journal:  Eur J Pain       Date:  2019-12-12       Impact factor: 3.931

Review 4.  Endogenous opioid peptides in the descending pain modulatory circuit.

Authors:  Elena E Bagley; Susan L Ingram
Journal:  Neuropharmacology       Date:  2020-05-15       Impact factor: 5.250

Review 5.  Mechanisms of placebo analgesia: A dual-process model informed by insights from cross-species comparisons.

Authors:  Scott M Schafer; Stephan Geuter; Tor D Wager
Journal:  Prog Neurobiol       Date:  2017-11-03       Impact factor: 11.685

Review 6.  Placebo eff ects in psychiatry: mediators and moderators.

Authors:  Katja Weimer; Luana Colloca; Paul Enck
Journal:  Lancet Psychiatry       Date:  2015-03       Impact factor: 27.083

Review 7.  Understanding placebo and nocebo responses for pain management.

Authors:  Luana Colloca; Christian Grillon
Journal:  Curr Pain Headache Rep       Date:  2014-06

Review 8.  Pain Modulation: From Conditioned Pain Modulation to Placebo and Nocebo Effects in Experimental and Clinical Pain.

Authors:  Janie Damien; Luana Colloca; Carmen-Édith Bellei-Rodriguez; Serge Marchand
Journal:  Int Rev Neurobiol       Date:  2018-08-14       Impact factor: 3.230

9.  Placebo analgesia and reward processing: integrating genetics, personality, and intrinsic brain activity.

Authors:  Rongjun Yu; Randy L Gollub; Mark Vangel; Ted Kaptchuk; Jordan W Smoller; Jian Kong
Journal:  Hum Brain Mapp       Date:  2014-02-27       Impact factor: 5.038

10.  Beyond conformity: Social influences on pain reports and physiology.

Authors:  Leonie Koban; Tor D Wager
Journal:  Emotion       Date:  2015-08-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.